Beth C. Seidenberg

3.9k total citations
20 papers, 3.1k citations indexed

About

Beth C. Seidenberg is a scholar working on Physiology, Pharmacology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Beth C. Seidenberg has authored 20 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Physiology, 9 papers in Pharmacology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Beth C. Seidenberg's work include Asthma and respiratory diseases (9 papers), Inflammatory mediators and NSAID effects (8 papers) and Respiratory and Cough-Related Research (7 papers). Beth C. Seidenberg is often cited by papers focused on Asthma and respiratory diseases (9 papers), Inflammatory mediators and NSAID effects (8 papers) and Respiratory and Cough-Related Research (7 papers). Beth C. Seidenberg collaborates with scholars based in United States, Canada and France. Beth C. Seidenberg's co-authors include Theodore F. Reiss, Elliot Ehrich, Barbara Knorr, Robert J. Dockhorn, James P. Kemp, Kerstin Malmström, James A. Bolognese, N. Bellamy, David J. Watson and Jonathan A. Bernstein and has published in prestigious journals such as New England Journal of Medicine, JAMA and Annals of Internal Medicine.

In The Last Decade

Beth C. Seidenberg

20 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Beth C. Seidenberg United States 18 1.7k 1.3k 1.0k 556 393 20 3.1k
Christopher H. Fanta United States 24 1.6k 1.0× 1.5k 1.1× 63 0.1× 148 0.3× 248 0.6× 56 2.4k
Rekha Chaudhuri United Kingdom 33 3.5k 2.1× 2.9k 2.1× 86 0.1× 424 0.8× 490 1.2× 116 4.4k
C. Warren Bierman United States 27 1.1k 0.7× 1.1k 0.8× 139 0.1× 153 0.3× 259 0.7× 97 2.0k
Richard Simons Canada 22 362 0.2× 347 0.3× 123 0.1× 636 1.1× 263 0.7× 44 2.3k
A Lockhart France 27 1.1k 0.6× 1.3k 1.0× 65 0.1× 244 0.4× 229 0.6× 103 2.4k
Irvin Mayers Canada 28 1.2k 0.7× 1.2k 0.9× 39 0.0× 532 1.0× 163 0.4× 107 3.0k
Michelle A. Carey United States 25 629 0.4× 545 0.4× 158 0.2× 311 0.6× 60 0.2× 52 2.3k
Chung‐Jen Yen Taiwan 28 872 0.5× 375 0.3× 82 0.1× 470 0.8× 23 0.1× 87 3.4k
Edwin A. Bronsky United States 32 2.7k 1.6× 2.0k 1.5× 108 0.1× 179 0.3× 1.4k 3.6× 56 3.4k
James P. Kemp United States 33 3.0k 1.8× 2.4k 1.8× 106 0.1× 144 0.3× 953 2.4× 107 3.7k

Countries citing papers authored by Beth C. Seidenberg

Since Specialization
Citations

This map shows the geographic impact of Beth C. Seidenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beth C. Seidenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beth C. Seidenberg more than expected).

Fields of papers citing papers by Beth C. Seidenberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beth C. Seidenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beth C. Seidenberg. The network helps show where Beth C. Seidenberg may publish in the future.

Co-authorship network of co-authors of Beth C. Seidenberg

This figure shows the co-authorship network connecting the top 25 collaborators of Beth C. Seidenberg. A scholar is included among the top collaborators of Beth C. Seidenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beth C. Seidenberg. Beth C. Seidenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reicin, Alise, Jessica Brown, Michael H. Bourne, et al.. (2001). Efficacy of single-dose and multidose rofecoxib in the treatment of post-orthopedic surgery pain.. PubMed. 30(1). 40–8. 67 indexed citations
2.
3.
Ehrich, Elliot, et al.. (2000). Minimal perceptible clinical improvement with the Western Ontario and McMaster Universities osteoarthritis index questionnaire and global assessments in patients with osteoarthritis.. PubMed. 27(11). 2635–41. 374 indexed citations
4.
Malmström, Kerstin, Guillermo Rodriguez-Gomez, César Villarán, et al.. (1999). Oral Montelukast, Inhaled Beclomethasone, and Placebo for Chronic Asthma. Annals of Internal Medicine. 156 indexed citations
5.
Löfdahl, C.-G., T.F. Reiss, Jared A. Leff, et al.. (1999). Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients. BMJ. 319(7202). 87–90. 195 indexed citations
6.
Malmström, Kerstin, Stephen Daniels, Paul Kotey, Beth C. Seidenberg, & Paul J. Desjardins. (1999). Comparison of rofecoxib and celecoxib, two cyclooxygenase-2 inhibitors, in postoperative dental pain: A randomized, placebo- and active-comparator-controlled clinical trial. Clinical Therapeutics. 21(10). 1653–1663. 219 indexed citations
7.
Morrison, Barclay, Søren T. Christensen, Wei Yuan, et al.. (1999). Analgesic efficacy of the cyclooxygenase-2-specific inhibitor rofecoxib in post-dental surgery pain: A randomized, controlled trial. Clinical Therapeutics. 21(6). 943–953. 197 indexed citations
8.
Santanello, Nancy C., et al.. (1999). What are minimal important changes for asthma measures in a clinical trial?. European Respiratory Journal. 14(1). 23–23. 207 indexed citations
9.
Knorr, Barbara, Jonathan Matz, Jonathan A. Bernstein, et al.. (1999). Montelukast for Chronic Asthma in 6- to 14-Year-Old Children: A Randomized, Double-Blind Trial. Survey of Anesthesiology. 43(1). 31–31. 36 indexed citations
10.
Ehrich, Elliot, Thomas J. Schnitzer, Harris McIlwain, et al.. (1999). Effect of specific COX-2 inhibition in osteoarthritis of the knee: a 6 week double blind, placebo controlled pilot study of rofecoxib. Rofecoxib Osteoarthritis Pilot Study Group.. PubMed. 26(11). 2438–47. 132 indexed citations
11.
Knorr, Barbara, Patrick Larson, Ha Nguyen, et al.. (1999). Montelukast Dose Selection in 6‐ to 14‐Year‐Olds: Comparison of Single‐Dose Pharmacokinetics in Children and Adults. The Journal of Clinical Pharmacology. 39(8). 786–793. 40 indexed citations
12.
Schnitzer, Thomas J., Roy Fleischmann, Joel A. Block, et al.. (1999). The safety profile, tolerability, and effective dose range of rofecoxib in the treatment of rheumatoid arthritis. Clinical Therapeutics. 21(10). 1688–1702. 110 indexed citations
13.
Pedinoff, A., et al.. (1999). Validation of an asthma symptom diary for interventional studies. Archives of Disease in Childhood. 80(5). 414–420. 51 indexed citations
14.
Morrison, Briggs, et al.. (1999). Rofecoxib, a Specific Cyclooxygenase-2 Inhibitor, in Primary Dysmenorrhea. Obstetrics and Gynecology. 94(4). 504–508. 8 indexed citations
15.
Daniels, S., et al.. (1999). Dose ranging trial of the effect of MK-966 in primary dysmenorrhea. Clinical Pharmacology & Therapeutics. 65(2). 118–118. 8 indexed citations
16.
Fricke, James R., Barclay Morrison, M. Sandler, et al.. (1999). MK-966 versus naproxen sodium, 550 MG in post-surgical dental pain. Clinical Pharmacology & Therapeutics. 65(2). 119–119. 37 indexed citations
17.
Brown, Jacques P., Barclay Morrison, Søren T. Christensen, et al.. (1999). MK-0966 50 MG versus ibuprofen 400 MG in post surgical dental pain. Clinical Pharmacology & Therapeutics. 65(2). 118–118. 31 indexed citations
18.
Leff, Jonathan A., David S. Pearlman, Edwin A. Bronsky, et al.. (1998). Montelukast, a Leukotriene-Receptor Antagonist, for the Treatment of Mild Asthma and Exercise-Induced Bronchoconstriction. New England Journal of Medicine. 339(3). 147–152. 424 indexed citations
19.
Knorr, Barbara, Jonathan Matz, Jonathan A. Bernstein, et al.. (1998). Montelukast for Chronic Asthma in 6- to 14-Year-Old Children. JAMA. 279(15). 1181–1181. 399 indexed citations
20.
Kemp, James P., Robert J. Dockhorn, Nguyen Hong Ha, et al.. (1998). Montelukast once daily inhibits exercise-induced bronchoconstriction in 6- to 14-year-old children with asthma. The Journal of Pediatrics. 133(3). 424–428. 202 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christopher H. Fanta Breakdown of academic impact, for papers by Rekha Chaudhuri Breakdown of academic impact, for papers by C. Warren Bierman Breakdown of academic impact, for papers by Richard Simons Breakdown of academic impact, for papers by A Lockhart Breakdown of academic impact, for papers by Irvin Mayers Breakdown of academic impact, for papers by Michelle A. Carey Breakdown of academic impact, for papers by Chung‐Jen Yen Breakdown of academic impact, for papers by Edwin A. Bronsky Breakdown of academic impact, for papers by James P. Kemp
Rankless by CCL
2026